PT86721A - Process for the preparation of a pharmaceutical compound containing the factor xiii of human blood coagulation - Google Patents

Process for the preparation of a pharmaceutical compound containing the factor xiii of human blood coagulation

Info

Publication number
PT86721A
PT86721A PT86721A PT8672188A PT86721A PT 86721 A PT86721 A PT 86721A PT 86721 A PT86721 A PT 86721A PT 8672188 A PT8672188 A PT 8672188A PT 86721 A PT86721 A PT 86721A
Authority
PT
Portugal
Prior art keywords
factor xiii
blood coagulation
human blood
preparation
compound containing
Prior art date
Application number
PT86721A
Other languages
English (en)
Other versions
PT86721B (pt
Inventor
Mikio Urabe
Satoshi Tanaka
Kenichiro Tsumura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12192122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT86721(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of PT86721A publication Critical patent/PT86721A/pt
Publication of PT86721B publication Critical patent/PT86721B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
PT86721A 1987-02-09 1988-02-08 Processo para a preparacao de uma composicao farmaceutica contendo o factor xiii da coagulacao sanguinea humano PT86721B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62026387A JPS63196520A (ja) 1987-02-09 1987-02-09 潰瘍性大腸炎治療剤

Publications (2)

Publication Number Publication Date
PT86721A true PT86721A (pt) 1988-03-01
PT86721B PT86721B (pt) 1992-05-29

Family

ID=12192122

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86721A PT86721B (pt) 1987-02-09 1988-02-08 Processo para a preparacao de uma composicao farmaceutica contendo o factor xiii da coagulacao sanguinea humano

Country Status (16)

Country Link
US (1) US5378687A (pt)
EP (1) EP0278416B1 (pt)
JP (1) JPS63196520A (pt)
KR (1) KR960014789B1 (pt)
AT (1) ATE83665T1 (pt)
AU (1) AU615428B2 (pt)
CA (1) CA1322161C (pt)
DE (1) DE3876817T2 (pt)
DK (1) DK63488A (pt)
ES (1) ES2052614T3 (pt)
GR (1) GR3007331T3 (pt)
HU (1) HU200277B (pt)
IE (1) IE61713B1 (pt)
IL (1) IL85346A (pt)
PT (1) PT86721B (pt)
ZA (1) ZA88852B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
AU3423493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Methods and compositions for reducing blood loss
US5514579A (en) * 1991-12-31 1996-05-07 Zymogenetics, Inc. Human transglutaminases
AU2002360269B2 (en) 2001-10-09 2007-03-22 Zymogenetics, Inc. Method for inhibiting the formation of seromas using factor XIII
AU2003273243A1 (en) * 2002-08-23 2004-03-11 Zymogenetics, Inc. Method for treating inflammatory bowel disease
EP1817339B1 (en) 2004-11-23 2012-01-11 ZymoGenetics, Inc. Purification of recombinant human factor xiii
US20140286927A1 (en) * 2012-06-19 2014-09-25 Peter Edward Smith Method for the treatment of ulcerative colitis in patients refractory to steroid therapy using leached ligand fibrin stabilizing composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法

Also Published As

Publication number Publication date
EP0278416A2 (en) 1988-08-17
DE3876817D1 (de) 1993-02-04
PT86721B (pt) 1992-05-29
EP0278416A3 (en) 1990-07-11
DK63488A (da) 1988-08-10
GR3007331T3 (pt) 1993-07-30
IL85346A (en) 1992-07-15
IE61713B1 (en) 1994-11-30
ES2052614T3 (es) 1994-07-16
ZA88852B (en) 1988-11-30
AU615428B2 (en) 1991-10-03
JPS63196520A (ja) 1988-08-15
IE880334L (en) 1988-08-09
HU200277B (en) 1990-05-28
JPH0437049B2 (pt) 1992-06-18
EP0278416B1 (en) 1992-12-23
IL85346A0 (en) 1988-07-31
CA1322161C (en) 1993-09-14
US5378687A (en) 1995-01-03
DK63488D0 (da) 1988-02-08
KR960014789B1 (en) 1996-10-19
DE3876817T2 (de) 1993-05-19
KR880009661A (ko) 1988-10-04
ATE83665T1 (de) 1993-01-15
AU1138288A (en) 1988-08-11
HUT47221A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
KR950009098B1 (en) Pharmaceutical composition for use in treating clot formation
EP0295331A3 (en) Use of vitamin e for normalizing the blood coagulation in the therapy with omega-3-type highly unsaturated fatty acids
ATE87836T1 (de) Katheter mit schraubenfoermigem ballon.
SE380435B (sv) Blodcirkulationshjelpapparat innefattande en ballong placerad i en patients arter
PT86721A (pt) Process for the preparation of a pharmaceutical compound containing the factor xiii of human blood coagulation
DK481388A (da) Calciumtilskud
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
ZA874198B (en) D-fenfluramine for use in the treatment of depression
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
DE19975044I2 (de) Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
EP0212310A3 (en) Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
FR2618672B1 (fr) Utilisation dans le traitement de l'acne et de la seborrhee d'une composition contenant un hydroperoxyde
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
IT1218512B (it) Apparecchio monouso schermante del viso nelle pratiche medicali
DK563886A (da) Terapeutisk komposition

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911118

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080208